(IHI) iShares U.S. Medical Devices - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888105 • Health
IHI: Medical Devices, Healthcare Equipment, Surgical Instruments
The iShares U.S. Medical Devices ETF (IHI) is designed to replicate the performance of the Dow Jones U.S. Select Medical Equipment Index. This index is tailored to measure the performance of companies within the medical equipment sector in the U.S. equity market, as defined by S&P Dow Jones Indices LLC. The fund offers exposure to a diverse range of medical equipment companies, including those involved in manufacturing and distributing critical devices such as MRI scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices.
As a non-diversified fund, IHI has the flexibility to concentrate its investments in a smaller number of securities, which can be beneficial for investors seeking targeted exposure to the medical devices sector. The fund is domiciled in the United States and is listed on the NYSE ARCA exchange. It is managed by BlackRock, Inc., a global leader in asset management, and provides investors with a cost-effective way to gain exposure to the medical devices industry.
With substantial assets under management totaling $5.167 billion, IHI is a significant player in the ETF landscape. The funds focus on the medical devices sector makes it an attractive option for investors looking to capitalize on the growth driven by an aging population, technological advancements, and increasing healthcare expenditure. The funds structure allows it to track the performance of its underlying index closely, providing investors with a reliable tool for accessing this dynamic sector.
Additional Sources for IHI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IHI ETF Overview
Market Cap in USD | 5,032m |
Category | Health |
TER | 0.40% |
IPO / Inception | 2006-05-01 |
IHI ETF Ratings
Growth 5y | 52.3% |
Fundamental | - |
Dividend | 49.9% |
Rel. Strength Industry | -6.08 |
Analysts | - |
Fair Price Momentum | 55.65 USD |
Fair Price DCF | - |
IHI Dividends
Dividend Yield 12m | 0.46% |
Yield on Cost 5y | 0.82% |
Annual Growth 5y | 14.79% |
Payout Consistency | 81.7% |
IHI Growth Ratios
Growth Correlation 3m | 56.6% |
Growth Correlation 12m | 84.4% |
Growth Correlation 5y | 34.6% |
CAGR 5y | 12.11% |
CAGR/Max DD 5y | 0.37 |
Sharpe Ratio 12m | 0.46 |
Alpha | -4.68 |
Beta | 0.53 |
Volatility | 19.01% |
Current Volume | 738.9k |
Average Volume 20d | 770.1k |
As of March 14, 2025, the stock is trading at USD 58.58 with a total of 738,865 shares traded.
Over the past week, the price has changed by -5.50%, over one month by -9.11%, over three months by -1.50% and over the past year by +1.66%.
Partly, yes. Based on ValueRay Analyses, iShares U.S. Medical Devices (NYSE ARCA:IHI) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 52.28 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHI as of March 2025 is 55.65. This means that IHI is currently overvalued and has a potential downside of -5%.
iShares U.S. Medical Devices has no consensus analysts rating.
According to ValueRays Forecast Model, IHI iShares U.S. Medical Devices will be worth about 61 in March 2026. The stock is currently trading at 58.58. This means that the stock has a potential upside of +4.06%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 61 | 4.1% |